Takayama, Ikuyo
Semba, Shohei
Yokono, Kota
Saito, Shinji
Nakauchi, Mina
Kubo, Hideyuki
Kaida, Atsushi
Shiomi, Masashi
Terada, Akihiro
Murakami, Kiyotaka
Kaji, Katsushi
Kiya, Keiichi
Sawada, Yoshitaka
Oba, Kunihiro
Asai, Sadasaburo
Yonekawa, Toshihiro
Watanabe, Hidetoshi
Segawa, Yuji
Notomi, Tsugunori
Kageyama, Tsutomu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19fk0108030, JP19fk0108030, JP19fk0108030, JP19fk0108030, JP19fk0108030, JP19fk0108030, JP19fk0108030)
Article History
Received: 15 April 2020
Accepted: 20 July 2020
First Online: 11 August 2020
Change Date: 30 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: S.Semba, K.Y., T.Y, H.W., Y.Segawa and T.N. are employed by Eiken Chemical Co., Ltd., which manufactures and sells Simprova system. The other authors declare no conflicts of interest.